Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 34

1.

Severe renal insufficiency is not an absolute pitfall to autologous stem cell transplantation with BeEAM (bendamustine, etoposide, cytarabine, melphalan) conditioning regimen.

Farnault L, Venton G, Pourroy B, Jourde-Chiche N, Ivanov V, Arcani R, Roche P, Mercier C, Colle J, Fanciullino R, Costello RT.

Bone Marrow Transplant. 2019 Jul;54(7):1173-1175. doi: 10.1038/s41409-019-0467-7. Epub 2019 Feb 4. No abstract available.

PMID:
30718799
2.

From 3D spheroids to tumor bearing mice: efficacy and distribution studies of trastuzumab-docetaxel immunoliposome in breast cancer.

Rodallec A, Sicard G, Giacometti S, Carré M, Pourroy B, Bouquet F, Savina A, Lacarelle B, Ciccolini J, Fanciullino R.

Int J Nanomedicine. 2018 Oct 23;13:6677-6688. doi: 10.2147/IJN.S179290. eCollection 2018. Erratum in: Int J Nanomedicine. 2018 Dec 31;14:335.

3.

Thrombotic microangiopathy associated with gemcitabine use: Presentation and outcome in a national French retrospective cohort.

Daviet F, Rouby F, Poullin P, Moussi-Francès J, Sallée M, Burtey S, Mancini J, Duffaud F, Sabatier R, Pourroy B, Grandvuillemin A, Grange S, Frémeaux-Bacchi V, Coppo P, Micallef J, Jourde-Chiche N.

Br J Clin Pharmacol. 2019 Feb;85(2):403-412. doi: 10.1111/bcp.13808. Epub 2018 Dec 18.

PMID:
30394581
4.

Acute myositis: an unusual and severe side effect of docetaxel: a case report and literature review.

Rochigneux P, Schleinitz N, Ebbo M, Aymonier M, Pourroy B, Boissier R, Salas S, Deville JL.

Anticancer Drugs. 2018 Jun;29(5):477-481. doi: 10.1097/CAD.0000000000000620. Review.

PMID:
29561309
5.

Recurrent extraneural sonic hedgehog medulloblastoma exhibiting sustained response to vismodegib and temozolomide monotherapies and inter-metastatic molecular heterogeneity at progression.

Petrirena GJ, Masliah-Planchon J, Sala Q, Pourroy B, Frappaz D, Tabouret E, Graillon T, Gentet JC, Delattre O, Chinot O, Padovani L.

Oncotarget. 2018 Jan 3;9(11):10175-10183. doi: 10.18632/oncotarget.23699. eCollection 2018 Feb 9.

6.

Development of a rapid risk evaluation tool for herbs/drugs interactions in cancer patients: a multicentric experience in south of France.

Pourroy B, Letellier C, Helvig A, Chanet B, De Crozals F, Alessandra C.

Eur J Cancer Care (Engl). 2017 Nov;26(6). doi: 10.1111/ecc.12752. Epub 2017 Sep 7.

PMID:
28881077
7.

Visual compatibility of blinatumomab with selected drugs during simulated Y-site administration.

Du Repaire T, Vigne P, Guedon A, Fanciullino R, Gauthier-Villano L, Peres PB, Pourroy B.

Am J Health Syst Pharm. 2017 Aug 15;74(16):1217-1218. doi: 10.2146/ajhp170111. No abstract available.

PMID:
28790072
8.

A simple and rapid LC-MS/MS method for therapeutic drug monitoring of cetuximab: a GPCO-UNICANCER proof of concept study in head-and-neck cancer patients.

Becher F, Ciccolini J, Imbs DC, Marin C, Fournel C, Dupuis C, Fakhry N, Pourroy B, Ghettas A, Pruvost A, Junot C, Duffaud F, Lacarelle B, Salas S.

Sci Rep. 2017 Jun 2;7(1):2714. doi: 10.1038/s41598-017-02821-x.

9.

Safety of chemotherapy prescription and production software: proposal of specific guidelines to test new versions.

Pourroy B, Benizri F, Roubaud S, Ruitort S.

Eur J Hosp Pharm Sci Pract. 2017 May;24(3):193. doi: 10.1136/ejhpharm-2016-000898. Epub 2016 Feb 26. No abstract available.

10.

Computerized Provider Order Entry Using Two Prescription-Writing Software in Oncology.

Guédon A, Rome A, Deville JL, Besse M, Blanchet L, Savry A, Gauthier-Villano L, Bertault-Peres P, Pourroy B.

Am J Med Qual. 2017 Mar/Apr;32(2):220. doi: 10.1177/1062860616666164. Epub 2016 Sep 23. No abstract available.

PMID:
27565815
11.

Safe Cytotoxic Drug Preparation Using Closed-system Transfer Device: Technical and Practical Evaluation of a New Device (Vialshield/Texium) Comparatively to a Reference One (Phaseal).

Garrigue P, Montana M, Ventre C, Savry A, Gauthier-Villano L, Pisano P, Pourroy B.

Int J Pharm Compd. 2016 Mar-Apr;20(2):148-54.

PMID:
27323425
12.

Keeping sterile 0.9% sodium chloride, 5% dextrose, and lactated Ringer's solutions for injection cold enough for dilution of decitabine in isolators.

Correard F, Savry A, Espitallier F, Villano LG, Pisano P, Pourroy B.

Am J Health Syst Pharm. 2016 Jun 1;73(11):748-50. doi: 10.2146/ajhp140625. No abstract available.

PMID:
27208058
13.

Stability of a highly concentrated solution of epirubicin for conventional transcatheter arterial chemoembolization.

Bennis Y, Savry A, Correard F, Montana M, Sauzet C, Gauthier-Villano L, Pisano P, Pourroy B.

Int J Pharm. 2015 Nov 30;495(2):956-62. doi: 10.1016/j.ijpharm.2015.10.012. Epub 2015 Oct 8.

PMID:
26453779
14.

[Pertinence of Off-label Prescriptions of Innovating and Expensive Drugs in a University Hospital].

Falabregues A, Daul M, Pourroy B, Gauthier-Villano L, Pisano P, Rathelot P, Vialettes B.

Therapie. 2015 Sep-Oct;70(5):385-402. doi: 10.2515/therapie/2015008. Epub 2015 Jul 3. French.

PMID:
26142399
15.

Visual compatibility of defibrotide with selected drugs during simulated Y-site administration.

Correard F, Savry A, Gauthier-Villano L, Pisano P, Pourroy B.

Am J Health Syst Pharm. 2014 Aug 1;71(15):1288-91. doi: 10.2146/ajhp130700.

PMID:
25027536
16.

Aseptic simulation test for cytotoxic drug production in isolators.

Savry A, Correard F, Bennis Y, Roubaud S, Gauthier-Villano L, Pisano P, Pourroy B.

Am J Health Syst Pharm. 2014 Mar 15;71(6):476-81. doi: 10.2146/ajhp130343.

PMID:
24589539
17.

Cisplatin dose adjustment in patients with renal impairment, which recommendations should we follow?

Bennis Y, Savry A, Rocca M, Gauthier-Villano L, Pisano P, Pourroy B.

Int J Clin Pharm. 2014 Apr;36(2):420-9. doi: 10.1007/s11096-013-9912-7. Epub 2014 Jan 17.

PMID:
24435159
18.

Keeping sterile water for injection cold enough for reconstitution of azacitidine in isolators.

Savry A, Correard F, Villano LG, Pisano P, Pourroy B.

Am J Health Syst Pharm. 2014 Feb 1;71(3):180-1. doi: 10.2146/ajhp130586. No abstract available.

PMID:
24429007
19.

SFPO and ESOP recommendations for the practical stability of anticancer drugs: an update.

Vigneron J, Astier A, Trittler R, Hecq JD, Daouphars M, Larsson I, Pourroy B, Pinguet F; French Society of Hospital Pharmacists; European Society of Oncology Pharmacists.

Ann Pharm Fr. 2013 Nov;71(6):376-89. doi: 10.1016/j.pharma.2013.06.002. Epub 2013 Aug 28.

PMID:
24206590
20.

CDA deficiency as a possible culprit for life-threatening toxicities after cytarabine plus 6-mercaptopurine therapy: pharmacogenetic investigations.

Ciccolini J, Evrard A, M'Batchi L, Pourroy B, Mercier C, Iliadis A, Lacarelle B, Verschuur A, Ouafik L, André N.

Pharmacogenomics. 2012 Mar;13(4):393-7. doi: 10.2217/pgs.11.175.

PMID:
22379997
21.

Incompatibility of imipenem-cilastatin and amoxicillin.

Pourroy B, Bausset EM, Boulamery A, Villano LG, Braguer D.

Am J Health Syst Pharm. 2009 Jul 15;66(14):1253-4. doi: 10.2146/ajhp090023. No abstract available.

PMID:
19574595
22.

High-dose methotrexate in adults with osteosarcoma: a population pharmacokinetics study and validation of a new limited sampling strategy.

Dupuis C, Mercier C, Yang C, Monjanel-Mouterde S, Ciccolini J, Fanciullino R, Pourroy B, Deville JL, Duffaud F, Bagarry-Liegey D, Durand A, Iliadis A, Favre R.

Anticancer Drugs. 2008 Mar;19(3):267-73.

PMID:
18510172
23.

Vinflunine, a novel microtubule inhibitor, suppresses calmodulin interaction with the microtubule-associated protein STOP.

Makarov AA, Tsvetkov PO, Villard C, Esquieu D, Pourroy B, Fahy J, Braguer D, Peyrot V, Lafitte D.

Biochemistry. 2007 Dec 25;46(51):14899-906. Epub 2007 Dec 4.

PMID:
18052208
24.

Efficacy of a combination of pemetrexed and multiple redo-surgery in an 11-year-old girl with a recurrent multifocal abdominal mesothelioma.

Milano E, Pourroy B, Rome A, Delarue A, Coze C, Gorincour G, Bouvier C, Braguer D, André N.

Anticancer Drugs. 2006 Nov;17(10):1231-4.

PMID:
17075325
25.

Therapeutic drug monitoring for dose individualization of Cisplatin in testicular cancer patients based upon total platinum measurement in plasma.

Salas S, Mercier C, Ciccolini J, Pourroy B, Fanciullino R, Tranchand B, Monjanel-Mouterde S, Baciuchka-Palmaro M, Dupuis C, Yang C, Balti M, Lacarelle B, Duffaud F, Durand A, Favre R.

Ther Drug Monit. 2006 Aug;28(4):532-9.

PMID:
16885721
26.

Dose individualization of carboplatin after a 120-hour infusion schedule: higher dose intensity but fewer toxicities.

Mercier C, Ciccolini J, Pourroy B, Fanciullino R, Duffaud F, Digue L, Tranchand B, Monjanel-Mouterde S, Guillet P, Nicoara A, Baciuchka M, Bagarry-Liegey D, Lacarelle B, Noble A, Durand A, Favre R.

Ther Drug Monit. 2006 Apr;28(2):212-8.

PMID:
16628133
27.

Antiangiogenic concentrations of vinflunine increase the interphase microtubule dynamics and decrease the motility of endothelial cells.

Pourroy B, Honoré S, Pasquier E, Bourgarel-Rey V, Kruczynski A, Briand C, Braguer D.

Cancer Res. 2006 Mar 15;66(6):3256-63.

28.

Decrease in c-Myc activity enhances cancer cell sensitivity to vinblastine.

Bressin C, Bourgarel-Rey V, Carré M, Pourroy B, Arango D, Braguer D, Barra Y.

Anticancer Drugs. 2006 Feb;17(2):181-7.

PMID:
16428936
29.

Seventy-two-hour stability of Taxol in 5% dextrose or 0.9% sodium chloride in Viaflo, Freeflex, Ecoflac and Macoflex N non-PVC bags.

Pourroy B, Botta C, Solas C, Lacarelle B, Braguer D.

J Clin Pharm Ther. 2005 Oct;30(5):455-8.

PMID:
16164492
30.

[Oxaliplatin neurotoxicity: a report of three cases with post-operative exacerbation].

Cournede A, Ries P, Richard K, Guillain A, Dahan L, Grandval P, Pourroy B, Moutardier V, Hardwigsen J, Braguer D, Seitz JF.

Gastroenterol Clin Biol. 2005 Apr;29(4):461-4. French.

31.

Antiangiogenic concentrations of paclitaxel induce an increase in microtubule dynamics in endothelial cells but not in cancer cells.

Pasquier E, Honore S, Pourroy B, Jordan MA, Lehmann M, Briand C, Braguer D.

Cancer Res. 2005 Mar 15;65(6):2433-40.

32.
33.

Low concentrations of vinflunine induce apoptosis in human SK-N-SH neuroblastoma cells through a postmitotic G1 arrest and a mitochondrial pathway.

Pourroy B, Carré M, Honoré S, Bourgarel-Rey V, Kruczynski A, Briand C, Braguer D.

Mol Pharmacol. 2004 Sep;66(3):580-91.

PMID:
15322250
34.

Paclitaxel targets mitochondria upstream of caspase activation in intact human neuroblastoma cells.

André N, Carré M, Brasseur G, Pourroy B, Kovacic H, Briand C, Braguer D.

FEBS Lett. 2002 Dec 4;532(1-2):256-60.

Supplemental Content

Loading ...
Support Center